Cargando…

How Can We Target Pulmonary Inflammation in Cystic Fibrosis?

Detalles Bibliográficos
Autor principal:	Greene, Catherine M.
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864425/ https://www.ncbi.nlm.nih.gov/pubmed/20448813 http://dx.doi.org/10.2174/1874306401004010018

Ejemplares similares

Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease
por: Jundi, Karim, et al.
Publicado: (2015)

How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey
por: Smith, Sherie, et al.
Publicado: (2020)

The Role of Sphingolipids and Ceramide in Pulmonary Inflammation in Cystic Fibrosis
por: Becker, Katrin Anne, et al.
Publicado: (2010)

Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis
por: Quinn, Derek J, et al.
Publicado: (2010)

Social Inequities and Cystic Fibrosis Outcomes: We Can Do Better
por: Oates, Gabriela R., et al.
Publicado: (2021)

Inflammation in Cystic Fibrosis
Publicado: (1996)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

MicroRNA Dysregulation in Cystic Fibrosis
por: McKiernan, Paul J., et al.
Publicado: (2015)

Can We Justify Cystic Fibrosis Mutational Analysis among Omani Neonates?
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2022)

Biomarkers of inflammation in infants with cystic fibrosis
por: Laguna, Theresa A., et al.
Publicado: (2018)

MicroRNA Expression in Cystic Fibrosis Airway Epithelium
por: Greene, Catherine M.
Publicado: (2013)

Mapping Pulmonary and Systemic Inflammation in Preschool Aged Children With Cystic Fibrosis
por: Shanthikumar, Shivanthan, et al.
Publicado: (2021)

Airway Epithelium Dysfunction in Cystic Fibrosis and COPD
por: De Rose, Virginia, et al.
Publicado: (2018)

Ivacaftor, not ivacaftor/lumacaftor, associated with lower pulmonary inflammation in preschool cystic fibrosis
por: Shanthikumar, Shivanthan, et al.
Publicado: (2022)

Letter in Reply: Can We Justify Cystic Fibrosis Mutational Analysis among Omani Neonates?
por: Al Balushi, Said, et al.
Publicado: (2022)

Infection, inflammation and exercise in cystic fibrosis
por: van de Weert-van Leeuwen, Pauline Barbera, et al.
Publicado: (2013)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Fungal Infection and Inflammation in Cystic Fibrosis
por: Poore, T. Spencer, et al.
Publicado: (2021)

Immunomodulation in Cystic Fibrosis: Why and How?
por: Giacalone, Vincent D., et al.
Publicado: (2020)

Cystic fibrosis modulator therapy can reverse cystic bronchiectasis
por: Middleton, Peter G., et al.
Publicado: (2023)

IRE1α Is a Therapeutic Target for Cystic Fibrosis Airway Inflammation
por: Hull-Ryde, Emily A., et al.
Publicado: (2021)

The Fitter the Better? Cardiopulmonary Exercise Testing Can Predict Pulmonary Exacerbations in Cystic Fibrosis
por: Kampouras, Asterios, et al.
Publicado: (2021)

Alpha-1 Antitrypsin—A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis
por: Hunt, Alison M.D., et al.
Publicado: (2020)

Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
por: McKiernan, Paul J, et al.
Publicado: (2013)

How are the ancient cystic fibrosis patients? Cystic fibrosis diagnosed over 60 years-old
por: Prados, C., et al.
Publicado: (2017)

Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

The Microbiome in Cystic Fibrosis Pulmonary Disease
por: Françoise, Alice, et al.
Publicado: (2020)

Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis?
por: Caverly, Lindsay J.
Publicado: (2022)

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis
por: De Rose, Virginia, et al.
Publicado: (2018)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
por: Harwood, Kiera H., et al.
Publicado: (2021)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Inflammation and Infection in Cystic Fibrosis: Update for the Clinician
por: Petrocheilou, Argyri, et al.
Publicado: (2022)

Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis
por: Lee, Jung M., et al.
Publicado: (2012)

Pulmonary aspiration in preschool children with cystic fibrosis
por: Clarke, D., et al.
Publicado: (2018)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Staphylococcus aureus and Cystic Fibrosis—A Close Relationship. What Can We Learn from Sequencing Studies?
por: Rumpf, Christine, et al.
Publicado: (2021)

Mitochondrial Stress Responses and “Mito-Inflammation” in Cystic Fibrosis
por: Patergnani, Simone, et al.
Publicado: (2020)

Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis
por: Öz, Hasan H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ekimvqubf7dqdiedo0d6ond7u